Handelsbanken Fonder’s Disc Medicine IRON Stock Holding History

Handelsbanken Fonder’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$929K	Buy	+12,700	New	+$873K	﹤0.01%	1173

Other funds holding IRON

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

IGAM

iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Handelsbanken Fonder's IRON Position: Q2 2026 in Review

Handelsbanken Fonder opened a new position in Disc Medicine (IRON) in Q2 2026: 12,700 shares worth $929K. The stake represents ﹤0.01% of the portfolio and ranks #1173 among its holdings.

30 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

Handelsbanken Fonder held 12,700 shares of Disc Medicine worth $929K as of Q2 2026.
Disc Medicine was a new Handelsbanken Fonder position in Q2 2026.
Disc Medicine made up ﹤0.01% of Handelsbanken Fonder's portfolio in Q2 2026, its #1173 holding.
30 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.